66. Expression and activity of muscle regulatory factors in normal and transformed muscle cells (Englisch)
Nationallizenz
- Neue Suche nach: Grossi, M
- Neue Suche nach: Russo, S
- Neue Suche nach: LaRocca, SA
- Neue Suche nach: Crescenzi, M
- Neue Suche nach: Zanetti, A
- Neue Suche nach: Falcone, G
- Neue Suche nach: Alemà, S
- Neue Suche nach: Tato, F
- Neue Suche nach: Grossi, M
- Neue Suche nach: Russo, S
- Neue Suche nach: LaRocca, SA
- Neue Suche nach: Crescenzi, M
- Neue Suche nach: Zanetti, A
- Neue Suche nach: Falcone, G
- Neue Suche nach: Alemà, S
- Neue Suche nach: Tato, F
In:
Biomedicine and Pharmacotherapy
;
46
, 5-7
;
270
;
1991
-
ISSN:
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:66. Expression and activity of muscle regulatory factors in normal and transformed muscle cells
-
Beteiligte:Grossi, M ( Autor:in ) / Russo, S ( Autor:in ) / LaRocca, SA ( Autor:in ) / Crescenzi, M ( Autor:in ) / Zanetti, A ( Autor:in ) / Falcone, G ( Autor:in ) / Alemà, S ( Autor:in ) / Tato, F ( Autor:in )
-
Erschienen in:Biomedicine and Pharmacotherapy ; 46, 5-7 ; 270
-
Verlag:
-
Erscheinungsdatum:01.01.1991
-
Format / Umfang:1 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Datenquelle:
Inhaltsverzeichnis – Band 46, Ausgabe 5-7
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 181
-
Foreword| 1991
- 183
-
Enhancement of differentiation and cytotoxicity of leukemia cells by combinations of fluorinated pyrimidines and differentiation inducers: development of DNA double-strand breaksWaxman, S / Huang, Y / Scher, BM / Scher, M et al. | 1991
- 193
-
Identity of differentiation inhibiting factor for mouse myeloid leukemia cells with Nm23/nucleoside diphosphate kinaseOkabe-Kado, J / Hozumi, M et al. | 1991
- 201
-
All-trans retinoic acid (ATRA) therapeutical effect in acute promyelocytic leukemiaDegos, L et al. | 1991
- 211
-
Therapy of ‘high risk’ myelodysplastic syndromes with an association of low-dose Ara-C, retinoic acid and 1, 25-dihydroxyvitamin D3De Rosa, L / Montuoro, A / De Laurenzi, A et al. | 1991
- 219
-
Innate chaos: I. The origin and genesis of complex morphologies and homeotic regulationBlazsek, I et al. | 1991
- 239
-
1. Cell cycle regulation and cellular senescenceBarrett, JC et al. | 1991
- 239
-
2. Differentiation in epidermal reconstituted tissues in vitro and in vivoBreitkreutz, D / Stark, HJ / Thiekötter, G / Tomakidi, P / Boukamp, P / Smola, H / Limat, A / Baur, M / Klein, E / Fusenig, NE et al. | 1991
- 240
-
4. Effects of DNA methylation on hepatitis B virus (HBV) transcription and binding of CREB and CREB-like proteins to the HBV promoterNicholson, R / Chen, L / Christman, JK et al. | 1991
- 240
-
3. Comparison of substrate specificity of mammalian and bacterial CpG DNA methyltransferases (MTases)Sheikhnejad, G / Marasco, C / Sufrin, J / Christman, JK et al. | 1991
- 241
-
5. Differential gene expression during senescence in cultureCristofalo, VJ / Pignolo, RJ / Cianciarulo, FL / DiPaolo, BR / Doggett, D / Rotenberg, MO et al. | 1991
- 241
-
6. Mesenchymal regulation of adult mouse mammary gland growth and differentiationGunha, GR / Young, P / Guzman, R / Nandi, S et al. | 1991
- 241
-
7. Retinoic acid (RA) and β-carotene (Car) slightly enhance papilloma but strongly inhibit carcinoma formation on the skin of Sencar miceDe Luea, LM et al. | 1991
- 242
-
8. Gene expression changes induced in human melanoma cells and SV40-immortalized human melanocytes exposed to differentiation inducing agentsJiang, H / Su, Zz / Lin, J / Fisher, PB et al. | 1991
- 242
-
9. Regulation of gene expression during squamous cell differentiationJetten, AM / Saunders, NA / Marvin, KW / George, MD / Fujimoto, W et al. | 1991
- 243
-
11. The human c-myc FUSE element binds a differentiation regulated protein with a novel structureDuncan, R / Avigan, M / Bazar, L / Krutzsch, H / Levens, D et al. | 1991
- 243
-
10. A positive cis-element of the human c-myc gene with homo-purine/homo-pyrimidine-like sequence binds proteins with unusual propertiesTakimoto, M / Michelotti, E / Matunis, M / Michael, M / Krutzsch, H / Dreyfuss, G / Levens, D et al. | 1991
- 244
-
13. Development of transgenic mouse models of skin carcinogenesis: potential applicationsRoop, DR / Rothnagel, JA / Bundman, DS / Longley, MA / Quintanilla, M / Greenhalgh, DA et al. | 1991
- 244
-
12. Discovery of new secreted protein marker of squamous differentiation (SqD), establishment of its relation to preprorelaxin and its regulation by retinoids in rabbit tracheal epithelial (RbTE) cellsLotan, R / Bemacki, SH / Pieniazek, J / Floyd, EE / George, M / Jetten, AM et al. | 1991
- 245
-
14. Expression of myc oncogene prevents muscle cell fusion, but not biochemical differentiation or commitment in the C2C12 myogenic cell lineCrescenz, M / Tato, F et al. | 1991
- 245
-
15. The biochemical control of normal epidermal differentiation and alterations in neoplastic transformationYuspa, SH / Dlugosz, A et al. | 1991
- 246
-
17. Characterization of mcl-1, a gene expressed in the early stages of myeloid leukemia cell differentiationCraig, RW / Kozopas, KM / Yang, T / Buchan, HL / Zhou, P et al. | 1991
- 246
-
16. Isolation and comparative analysis of the Hematon and the cubbleston area forming cells reveal homologous functional units in the human or murine bone marrowBlazsek, I / Liu, SH / Quittet, P / Anjo, A / Reynes, M / Comisso, M / Misset, JL et al. | 1991
- 247
-
19. The role of protein phosphorylation and dephosphorylation at tyrosine residues in cellular differentiationWatanabe, T / Kume, T / Konno, K / Oishi, M et al. | 1991
- 247
-
18. The effect of M20 IL-1 inhibitor on the proliferation and differentiation of human hemopoietic cellsPeled, T / Rigel, M / Treves, AJ / Barak, V / Fibach, E et al. | 1991
- 248
-
21. Cascade transactivation of growth factors receptors in early hematopoiesisTesta, U / Pelosi, E / Gabbianelli, M / Fossati, C / Campisi, S / Isacchi, G / Mastroberardino, G / Peschle, C et al. | 1991
- 248
-
20. Expression of the transcription factor GATA-1 and of erythropoietin receptor in growth factor dependent erythroid and non-erythroid cell linesOttolenghi, S / Migliaccio, AR / Crotta, S / Bertini, C / Barren, C / Ronchi, A / Nicolis, S / Quintini, GL / Komatsu, N / Jiang, Y et al. | 1991
- 249
-
23. Cytokines/stromal cells in hematopoietic microenvironment influence proliferation/differentiation of acute myeloid leukemia cellsRaza, A / Kadam, P / Preisler, H et al. | 1991
- 249
-
22. Pure human hematopoietic progenitors in liquid culture: a model for selective/synchronized differentiation along the erythroid or granulomonocytic lineageValtieri, M / Testa, U / Samoggia, P / Gabbianelli, M / Isacchi, G / Camagna, A / Peschle, C et al. | 1991
- 250
-
25. Expression of the erythroid-specific transcription factor GATA-1 in human myeloid leunkenic cellsSaglio, G / Camaschella, C / Guerrasio, A / Alfarano, A / Rosso, C / Biondi, A / Rambaldi, A / Nicolis, S / Ottolenghi, S et al. | 1991
- 250
-
24. Modulation of ferritin H-chain expression in Friend erythroleukemia cells: transcriptioaal and translational regulation by heminCoccia, EM / Profita, V / Fiorucci, G / Romeo, G / Affabris, E / Testa, U / Hentze, MW / Battistini, A / Rossi, GB et al. | 1991
- 251
-
26. Precommitment gene expression changes during mouse erythroleukemia cell differentiation and their relationship to c-mycSkoultchi, A / Cheng, G / Krimer, D / Rao, G / Austin, C et al. | 1991
- 251
-
27. Cell death and differentiation in human myeloid leukemia cellsYoshida, Y / Anzai, N / Hirama, T / Kawabata, H / Masutani, H et al. | 1991
- 252
-
29. DCC gene expression and function in neuronal differentiationRisinger, I / Boyd, J et al. | 1991
- 252
-
28. Induction of p52 (PAI-1) gene expression and generation of the flat revertant phenotype in v-ras-transformed rat kidney cells by sodium butyrateA, H / Higgins, PJ et al. | 1991
- 253
-
30. Proto-oneogene jun-D acts as a functional tumor suppressor gene in fibroblasts and mammary carcinoma cellsBrysch, W / Schlingensiepen, KH et al. | 1991
- 253
-
31. Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotidas in transformed neuroectodermal cell linesRaschella, G / Negreni, A / Skorski, T / Pucci, S / Nieborowska-Skorska, M / Romeo, A / Calabretta, B et al. | 1991
- 254
-
33. Structural homology between RB and P53 and the functional significanceFung, YT / Driscoll, B / T'Ang, A et al. | 1991
- 254
-
32. A suppressor of the phenotypic expression of ras encodes lysyl oxidaseKenyon, K / Contente, S / Trackman, PC / Tang, J / Kagan, HM / Friedman, RM et al. | 1991
- 255
-
35. Use of anti-sense knock-out approach for cloning new genes that suppress cell growthKimchi, A / Deiss, L / Berissi, H et al. | 1991
- 255
-
34. p53 tumor suppressor gene involvement in human carcinogenesisHarris, CC / Hollstein, MC / Bennett, WP / Hsu, IC / Spillare, E / Gerwin, BI et al. | 1991
- 256
-
36. Tanscriptional regulation by p53 is modulated by oligomerizationMiller, CW / Chumakov, A / Aslo, A / Chen, DL / Koeffler, HP et al. | 1991
- 256
-
37. Modulation of gene expression during anthracycline treatment of K562 leukemia cells and doxorubicin-resistant K562 cells: relationship to growth inhibition and erythroid differentiationMazouzi, Z / Francastel, C / Castagna, M / Robert-Lézénès, J et al. | 1991
- 257
-
39. Involvement of the retinoblastoma (Rb) protein in the regulation of ceil differentiationSzekely, L / Jiang, WQ / Savatier, P / Bulic-Jakus, F / Wendel-Hansen, V / Rosen, A / Ringertz, N / Klein, G / Wiman, KG et al. | 1991
- 257
-
38. Specific inhibition of different jun genes either inhibits or stimulates cell differentiationSchlingensiepen, KH / Brysch, W et al. | 1991
- 258
-
41. The ras oncogene as a therapeutic targetWood, AW et al. | 1991
- 258
-
40. Regulation of phosphorylation of the retinoblastoma gene productT'Ang, A / Driscoll, B / Fung, YK T et al. | 1991
- 258
-
42. Tumor suppressor gene expression responds to chemotherapeutic drugsYen, A / Varvayanis, S et al. | 1991
- 259
-
44. Growth factor-dependent inhibition of normal hematopoiesis by N-ras antisens oligodeoxynucieotidesSkorski, T / Szczylik, C / Ratajczak, MZ / Malaguarnera, L / Gewirtz, AM / Calabretta, B et al. | 1991
- 259
-
43. JUND transactivates reporter gene expression driven by c-myb promoter via an Ap1-like elementNicolaides, NC / Correa, I / Casadevall, C / Travail, S / Soprano, KJ / Calabretta, B et al. | 1991
- 260
-
45. Regulation of BcI-2 and cell death by all-trans retinoic acid in acute promyelocytic leukemic cellsChomiennc, C / Barbey, S / Balitrand, N / Degos, L / Sachs, L et al. | 1991
- 260
-
46. Therapeutic utility of antisense (AS) oligodeoxynucleotides in vitro and in vivoRatajczak, MZ / Luger, S / Hijiya, N / Calabretta, B / Gewirtz, A et al. | 1991
- 260
-
47. Interleukin-6 modifies cell cycle controlling, nuclear proteins in M1 myeloblastic cellsKimchi, A / Melamed, D / Resnitzky, D / Tiefenbrun, N / Levy, N / Zafriri, D et al. | 1991
- 261
-
49. Antisense RNA of the latent period gene (MER5) inhibits erythroleukemic differentiationNemoto, Y / Tsuji, TK / Yamamoto, T / Takada, S / Matsui, Y / Obinata, M et al. | 1991
- 261
-
48. The TCL-3 (HOX-11) proto-oncogene is a cell-type-specific regulatory factor in the hematopoietic systemLu, M / Zhang, N / Ho, A et al. | 1991
- 262
-
51. Alteration of Myb and Myc expression in acute myelogenous leukemia cells (AML) in vivo in patientsPreisler, HD / Gopal, V / Banavali, SD / Raza, A et al. | 1991
- 262
-
50. Role of c-Myc on erythroleukemic differentiationObmori, Y / Tanabe, J / Terashima, M / Nemoto, Y / Shoji, W / Takada, S / Obinata, M et al. | 1991
- 263
-
53. Induction of H1 histone gene expression during mouse erythroleukemia cell differentiationSkoultchi, A / Cheng, G / Dong, Y / Liu, D / Sirotkin, A et al. | 1991
- 263
-
52. Transforming growth factor-β (TGF-β) inhibits phosphorylation of the retinoblastoma susceptibility gene product in human monocytic leukemia cell line JOSK-IFurukawa, Y / Ohta, M / Tsunoda, A / Griffin, JD / Saico, M et al. | 1991
- 264
-
54. Dissociation of functional monocytic differentiation of myeloid leukemia cells from monokine mRNA and protein expression by the use of pentoxifylline and dexamethasoneWeinberg, JB / Mason, SN / Wortham, TS / Nutter, DA et al. | 1991
- 265
-
56. Role of keratinocyte growth factor in androgen-dependent development of the neonatal mouse seminal vesicleAlarid, ET / Cunha, OR / Rubin, J et al. | 1991
- 265
-
55. Suppression of growth factor gene expression with antisense DNA. A novel approach to tumor growth modulationBrysch, W / Bogdahn, U / Behl, C / Schlingensiepen, KH et al. | 1991
- 266
-
57. Structural interactions of the GM-CSF/IL-3 receptor complexDiPersio, J / Doshi, P / Rapoport, A / Venepalli, J et al. | 1991
- 266
-
58. The potential of human myeloid leukemic cells to undergo spontaneous differentiation in vitro and their response to differentiation-inducing-agentsFibach, E / Peled, T / Rachmilewitz, EA et al. | 1991
- 267
-
60. Neural differentiation is regulated by the interaction of activin and foliistatinHashimoto, M / Eto, Y / Yamada, R / Muramatsu, M et al. | 1991
- 267
-
59. Stimulation of erythroid progenitors by high concentrations of erythropoietin results in normoblasts arrested in G2 phase of the cell cycleFibach, E / Rachmilewitz, EA et al. | 1991
- 268
-
61. Identity of differentiation inhibiting factor for mouse myeloid leukemia cells with Nm23/nucleoside diphosphate kinaseOkabe-Kado, J / Hozumi, M et al. | 1991
- 268
-
62.The role of the epidermal growth factor receptor (EGFR) in squamous differentiation of human lung cancer cell linesLevitt, ML / Ferri, W / Mayotte, J / Kane, P / Fitz, T / Gazdar, A / Stromberg, K / Sausvilie, EA et al. | 1991
- 269
-
63. In vitro reconstruction of erythropoietic microenvironment by the established stromai cellsYanai, N / Ohneda, O / Obinata, M et al. | 1991
- 269
-
64. Structure-function analyses of human granulocyte-macrophage colony stimulating factor using synthetic peptides and antibodiesBeffy, P / Rovero, P / Di Bartolo, V / Trombi, L / Laricchia, L / Revoltella, RP et al. | 1991
- 270
-
65. Enterotoxin, and ADP-ribosylation toxin, remarkably enhances TNF-induced differentiation of human myeloblastic kukemia ML-1 cellsTakeda, K / Iwanami, M / Kumakura, S / Iwamoto, S / Tsuji, T / Miyama, A et al. | 1991
- 270
-
66. Expression and activity of muscle regulatory factors in normal and transformed muscle cellsGrossi, M / Russo, S / LaRocca, SA / Crescenzi, M / Zanetti, A / Falcone, G / Alemà, S / Tato, F et al. | 1991
- 271
-
67. Stimulation and priming of human neutrophils by interleukin 8: cooperation with tumor necrosis factor and colony-stimulating factorsYuo, A / Azuma, E / Kitagawa, S / Kasahara, T / Matsushima, K / Saito, M / Takaku, F et al. | 1991
- 272
-
69. Interactions between breast normal stroma and breast epithelial cellsCalvo, F / Millot, G / Degeorges, A / de Cremoux, P / Boiron, M et al. | 1991
- 272
-
68. Introduction of a gonadotropin receptor gene to immortalized granulosa cells leads to reconstitution of hormone-dependent steroidogenesis and suppression of cell growthSuh, BS / Sprengel, R / Keren-Tal, I / Himmelhoch, S / Amsterdam, A et al. | 1991
- 273
-
70. Expression of protein kinase C isoforms in human colon carcinoma cells HT-29 as related to cell differentiationFrezouls, G / Lesuffleur, T / Castagna, M et al. | 1991
- 273
-
71. Growth-promoting paracrine effects of preputial gland mesenchyme on adult mouse mammary epithelial cells: Role of keratinocyte growth factorCunha, GR / Young, P / Guzman, R / Nandi, S / Imagawa, W / Rubin, J et al. | 1991
- 274
-
73. Identification of novel tyrosine (Y) and serine/threonine (S/T) kinases in resting and activated human stem cellsDiPersio, J / Luhowsky, S et al. | 1991
- 274
-
72. GM-CSF directly induces neutrophil platelet activating factor (PAF) and leukotriene B4 (LTB4) synthesis: activation of the lysoPAF acetyltransferase through a tyrosine ki-nase-dependent signaling cascadeDiPersio, J / Abboud, C / Aggarwal, S / Golde, D et al. | 1991
- 275
-
74. Cross-coupling between the retinoic acid (RA) and protein kinase C (PKC) pathways potentiates RA-mediated human teratocarcinoma (TC) differentiationKurie, J / Younes, A / Miller, WH Jr / Kolesnick, R / Dmitrovsky, E et al. | 1991
- 275
-
75. Enhanced proliferation and differentiation of mouse hematopoietic progenitor cells in response to fibroblastic and adipogenic cell contactHangoc, G / Daub, R / Maze, RG / Broxmeyer, HE / Harrington, MA et al. | 1991
- 276
-
76. Membrane alterations associated with hexamethylene bisacetamide (HMBA) induced differentiation of murine erythroleukemia cells (MELC)Michaeli, J / Busquets, X / Escriba, PV / Colomer, D / Richon, V / Marks, PA / Rifkind, R et al. | 1991
- 276
-
77. Total metabolic flow of glycosphingolipid biosynthesis is regulated by activities of UDP-G1cNAc: lactosylceramide β1→3 N-acetylglucosaminyltransferase and CMP-NeuAc: lac-tosylceramide α2→3 siaiyltransferase in human hematopoietic cell line HL-60 during differentiationNakamura, M / Tsunoda, A / Sakoe, K / Gu, J / Nishikawa, A / Taniguchi, N / Saito, M et al. | 1991
- 277
-
78. Effects of inhibitors of protein kinase activities on differentiation of human myeloid leukemia cellsMakishima, M / Sampi, K / Honma, Y / Hozumi, M et al. | 1991
- 277
-
79. Over expression of protein kinase subunits differentially affects morphology, growth and differentiation of human and rodent epithelial cellsTortora, G / Pepe, S / Baldassarre, G / Bianco, C / S Cho-Chung, Y / R Bianco, A / Ciardiello, F et al. | 1991
- 278
-
80. Induction of tumor suppression/cell senescence in human melanoma cells following transfection of protein kinase C βII geneYamanishi, DT / Buckmeier, JA / Meyskens, FL Jr et al. | 1991
- 279
-
82. Suppressive effects of human proinflammatory cytokines on proliferation of human myeloid progenitor cellsBroxmeyer, HE / Sherry, B / Cooper, S / Lu, L / Maze, R / Beckmann, MP / Cerami, A / Ralph, P et al. | 1991
- 279
-
81. Cyclic AMP suppresses metastatic spread in nude mice of steroidogenic rat granulosa cells transformed by SV40 and Ha-ras oncogeneSuh, BS / Eisenbach, L / Amsterdam, A et al. | 1991
- 280
-
84. Regulation of differentiation in lung carcinoma: paracrine control by glucocorticoids and lung fibroblastsFreshney, RI / McCormick, C / Speirs, V et al. | 1991
- 280
-
83. Interferon (IFN) and sarcolectin in the regulation of growth and differentiationChany, C / Chany-Fournier, F / Jiang, P-H et al. | 1991
- 281
-
86. Herbimycin A, an inhibitor of tyrosine kinase prolongs survival of mice inoculated with myeloid leukemia C1 cells with high expression of v-abl tyrosine kinaseHonma, Y / Hozumi, M et al. | 1991
- 281
-
85. Molecular and biological characteristics of a potentially novel human gastric tumor antigenShimada, S / Schlom, J / Ogawa, M / Greiner, JW et al. | 1991
- 282
-
88. Antitumor effects of human IL-6 in murine leukemia and solid tumor modelsRevel, M / Haran-Ghera, N / Katz, A / Eisenbach, L / Feldman, M / Slavin, S et al. | 1991
- 282
-
87. Modulation of growth and differentiation in human epidermal and tracheobronchial keratinocytes by interferon γJetten, AM / Saunders, NA / George, MD et al. | 1991
- 282
-
89. Differentiation of myeloleukemic M1 cells: role of early gene activations by IL-6 and IFNRevel, M / Harroch, S / Gothel, Y / Chebath, J et al. | 1991
- 283
-
90. Encapsulation of interferons in liposomes increases their biological activitiesReiter, Z / Klein, S / Taylor, W et al. | 1991
- 283
-
91. Impact of anti-c-myc DNA on differentiation and MHC class I antigens of leukemic cellsWickstrom, E / Bacon, TA / Crall, KS et al. | 1991
- 284
-
92. Capacity-limited metabolism of all-trans-retinoic add and the time course of enzyme induction of the non-human primateAdamson, PC / Balis, FM / Smith, MA / Murphy, RF / Godwin, KA / Boylan, JF / Gudas, LJ / Poplack, DG et al. | 1991
- 284
-
93. Retinoids up-regulate expression of connexion 43 in human and mouse cells: implication for growth control and differentiationBertram, JS / Hozzain, MZ / Zhang, LX / Guo, H et al. | 1991
- 285
-
94. Retinoylation of the cAMP-binding regulatory subunits of cAMP-dependent protein kinases in HL60 cellsTakahashi, N / Liapi, C / Anderson, WB / Breitman, TR et al. | 1991
- 285
-
95. Effect of retinoids on the anchorage-independent growth of JB6 epidermal cellsRudd, CJ / Suing, K / Dawson, MI et al. | 1991
- 286
-
97. Identification of a retinoic acid responsive enhancer 3′ of the murine homeobox gene Hox-1.6Langsten, AW / Gudas, LJ et al. | 1991
- 286
-
96. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell linesHu, L / Crowe, DL / Rheinwald, JG / Chambon, P / Gudas, LJ et al. | 1991
- 287
-
98. Catabolism of all-trans-retinoic acid by human cell microsomes selectively enriched in specified cytochrome P-450 enzymesMuindi, J / Young, C et al. | 1991
- 288
-
100. Functions of retinoid binding proteins in maintaining retinoic acid homeostasisNapoli, JL / Fiorella, PD / Boerman, MHEM / Posch, KC et al. | 1991
- 288
-
99. Studies on the bioavailability of orally administered all-tarns-retinoic acid in cancer patients; its modulation by ketoconazoleMuindi, J / Young, C / Rigas, J / Francis, P / Kris, M / Scher, H / Kelly, WK / Warrell, R Jr et al. | 1991
- 289
-
102. Coordinate regulation of oncogenes, suppressor genes and cell cycle genes in human neuroblastoma cell lines sensitive to retinoic acid and its disruption in NB cells constitutively expressing IGF-IIThiele, CJ / Gaetano, C / Matsumoto, K et al. | 1991
- 289
-
101. Structural/functional analyses of a retinoic acid regulated promoterStein, JP / Gilsdorf, JS / Burrell, TA / Hozza, MJ et al. | 1991
- 290
-
104. Is acute promyelocytic leukemia (APL) a homogenous disease?Chen, Z / Chen, SJ / Sun, GL / Li, XS / Cal, JR / Wang, ZY et al. | 1991
- 290
-
103. The retinoic acid receptor alpha (RARA) gene is fused with a transcription unit on chromosome 11q in an Acute promyelocytic leukemia (APL) patient with variant t(11;17) translocationChen, SJ / Chen, Z / Tong, JH / Chen, A / Wang, ZY / Le Coniat, M / Berger, R / Zelent, AZ / Waxman, S et al. | 1991
- 291
-
105. Function of normal and latered retinoic acid binding proteins in acute promyelocytic leukemiaChomienne, C / Frazhanet, F / Cornic, M / Rousselot, P / Castaigne, S / Degos, L / de Thé, H / Lefebvre, P / Balitrand, N et al. | 1991
- 291
-
107. The t(15;17) translocation of acute promyelocytic leukemia generates a functionally altered retinoic acid receptorDejean, A / Lavau, C / Chomienne, C / Marchio, A / Degos, L / de Thé, H et al. | 1991
- 291
-
106. The t(15,17) translocation of acute promyelocytic leukemia generates a structuraly altered retinoic acid receptorDejean, A / Lavau, C / Chomienne, C / Marchio, A / Degos, L / de Thé, H et al. | 1991
- 292
-
109. Differential regulation of PML-RARα and RARα1 mRNAs following trans-retinoic acid (tRA) treatment of acute promyelocytic leukemia (APL) cellsGallagher, R / Zelent, A / Zhang, S / Peng, S / Rao, S / Sagayadan, G / Waxman, S / Wiernik, P et al. | 1991
- 292
-
108. PML: a new zinc finger protein involved in the t(15;17) translocation of acute promyelocytic leukemiade Thé, H / Lavau, C / Chomienne, C / Marchio, A / Degos, L / Dejean, A et al. | 1991
- 293
-
111. Characterization of the acute promyelocytic leukemia (APL) specific t(15;17) PML-RARα chimeric productNervi, C / Poindexter, EE / Grignani, F / Pandolfi, PP / Pelicci, PG / Jetten, AM et al. | 1991
- 293
-
110. Molecular genetics of the t(15;17) of acute promyelocytic leukemias (APL)Grignani, Fr / Pandolfi, PP / Alcalay, M / Fagioli, M / Mencarelli, A / Grignani, F / Pelicci, PG et al. | 1991
- 294
-
113. Reverse transcription polymerase chain reaction (RT-PCR) for the rearranged retinoic acid receptor-α (RAR-α) predicts response of acute promyelocytic leukemia (APL) to retinoic acid (RA) therapy and detects minimal residual diseaseMiller, WH Jr / Kakizuka, A / Frankel, SR / Warrell, RP Jr / DeBlasio, A / Arlin, Z / Evans, RM / Dmitrovsky, E et al. | 1991
- 294
-
112. PML-RAR. A fusion protein in human acute promyelocytic leukemiaKakizuka, A / Dyck, JA / Evans, RM et al. | 1991
- 295
-
115. All-trans retinoic acid drug development at the national cancer institute (NCI)Parkinson, DR / Stevenson, HC / Smith, A / Cheson, BD / Friedman, A et al. | 1991
- 295
-
114. Novel chimeric mRNA expressed in APL patient with a variant t(11;17) reciprocal chromosomal translocation between RAR-α and previously uncharacterised TFIIIA-like zinc-finger encoding gene on chromosome 1123Zelent, A / Chen, SJ / Chen, Z / Brand, N / Tong, JH / Geng, JP / Yu, HQ / Chen, A / Waxman, S et al. | 1991
- 296
-
116. Resistance to retinoic acid and nuclear receptors for retinoic acid in human renal cell carcinoma and breast carcinoma ceil lines: possible role as tumor suppressor genes in kidney and breast cancerVan der Saag, PT / Van der Drinu, CE / Ubert, T / Kwakkombes, L / van der Leede, DJ / Opdenoordt, T / de Laat, SW / van der Burg, B et al. | 1991
- 297
-
118. Changes in the levels of constitutively expressed but not stress-induced heat shock proteins during terminal differentiation of HL-60 human leukemia cellsBeere, HM / Morimoto, RI / Waters, CM / Parmar, R / Hickman, JA et al. | 1991
- 297
-
117. Theoretical and practical considerations in high-throughput screening for differentiation agentsFrancis, GE et al. | 1991
- 298
-
121. Effects of retinoic acid, interferon and granulocyte-macrophage colony stimulating factor on human leukemic cells and the hematopoietic microenvironment in vivoRaza, A / Preisler, H et al. | 1991
- 298
-
120. Modulation of gene expression through inhibiting guanylate metabolismOláh, E / Csókay, B / Papp, J et al. | 1991
- 298
-
119. Hexamethylene bisacetamide (HMBA)-induced reduction in diacylglycerol levels is associated with differentiation of murine erythroleukemia cellsMichaeli, J / Kolesnick, RN / Busquets, X / Marks, PA / Rifkind, R et al. | 1991
- 299
-
124. Sodium butyrate induces transcription of promoters adjacent to a viral enhancer sequenceTaylor, MW / Yeivin, A et al. | 1991
- 299
-
122. Inhibition of the binding of granulocyte-macrophage colony stimulating factor (GM-CSF) and insulin to human leukemia cells by the differentiation-inducer dimethylsulfoxideSchwanz, EL / Chamberlin, H / Ravichander, P / Whitbread, A et al. | 1991
- 299
-
123. Reversal of enzyme phenotype of thymidine metabolism in induced differentiation of leukemia cellsYamaji, Y / Shiotani, T / Hashimoto, Y / Fujita, J / Ikeda, K / Tanaka, T / Takahara, J / Irino, S et al. | 1991
- 300
-
126. Analysis of the developmental regulation of RNA stability in differentiating murine erythroleukemia (MEL) cells with the use of a cell free systemChristou, IE / Tsiftsoglou, AS et al. | 1991
- 300
-
125. Expression of GATA-1 and NFE-2 erythroid-specific transfactors during aclacinomy-cin-mediated differentiation of human erythroleukemic cellsTrecitesaux, C / Nyoung, M Ngo / Aries, A / Ronchi, A / Ottolenghi, S / Jardillier, JC / Jeannesson, P et al. | 1991
- 301
-
127. Detection of receptor-like proteins for [2-(3-ethyluredo)-6-acetylamino-pyridine] (UDP), an inducer of differentiation, in murine erythroleukemia (MEL) cellsPappas, IS / Tsiftsoglou, AS et al. | 1991
- 302
-
128. Altered expression of cell cycle-related genes during the differentiation induced by TPA or DMSO in HL60 cellsHoriguchi-Yamada, J / Yamada, H et al. | 1991
- 303
-
130. Suppression of growth of human colon carcinoma in athymic mice by antisense oligodeoxynucleotides against type I regulatory subunit of cAMP-dependent protein kinaseCho-Chung, Yis / Clair, T / Meissner, S et al. | 1991
- 303
-
129. Role of type I regulatory subunit (RI) of cAMP dependent protein kinase (PKA) in multidrug resistance (mdr) of cancer cellsCho-Chung, YS / Budillon, A / Clair, T et al. | 1991
- 304
-
131. Ro 40-8757, a new aretinoid with antitumor activity in vivo and in vitroEmmons, R / Teelmann, K / Klaus, M / Eliason, J et al. | 1991
- 304
-
132. The protein kinase inhibitor staurosporine induces differentiation of neoplastic mouse keratinocytes in vitro and blocks their growth as benign epidermal tumors in vivoDlugosz, A / Strickland, JE / Hennings, H / Yuspa, SH et al. | 1991
- 305
-
134. Stimulatory and inhibitory effects of DNA topoisomerase II (Topo II) inhibitors on colony formation of human bone marrow progenitor cellsTejedor, MC / Chresta, C / Berney, J / Delgado, C / Francis, GE et al. | 1991
- 305
-
133. PEG-cytokines: improved pharmaceutical properties and dissociation of individual bioactivitiesFrancis, GE / Fisher, D / Delgado, C / Domine, M / Malik, F / Smith, OP / Tejedor, MC et al. | 1991
- 306
-
135. Cell differentiation of HL-60 cells induced by Boswellic acid (BC4) an active principle from Boswellia cartorii BirdwJing, YK / Han, J et al. | 1991
- 306
-
136. Pharmacological studies and clinical application of N-4-(carboxyphenyl) retinamide (RII) for the treatment of premalignanciesHan, J / Lu, Y / Gu, QM et al. | 1991
- 307
-
137. Differentiation control in human breast tumor cells by okadaic acid and related phosphatase inhibitorsHuberman, E / Kiguchi, K / Chubb, C / Giometti, C / Fujiki, H et al. | 1991
- 307
-
138. In vitro anticancer drug screening using differentiation assaysMaurer, HR / Hilgard, P et al. | 1991
- 308
-
140. Inhibition of chemical carcinogenesis in vivo by azatyrosineIzawa, M / Takayama, S / Shindo-Okada, N / Doi, S / Kimura, M / Katsuki, M / Nishimura, S et al. | 1991
- 308
-
139. Differentiation-inducing activity of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piper-azinyl]-2(1H)-quinolinone (vesnarinone) against tumor leukemia and solid tumor cellsNakai, S / Aihara, K / Kawai, K / Ogino, K / Saitou, F / Sato, M / Adachi, M et al. | 1991
- 309
-
141. Genes specifically expressed in flat revertant cells derived from ras-transformed cell by the treatment with azatyrosineKrzyzosiak, WJ / Shindo-Okada, N / Teshima, H / Nakajima, K / Nishimura, S et al. | 1991
- 309
-
142. Induction of in vitro differentiation of mouse embryonal carcinoma (F9) cells by inhibitors of topoisomerasesTsuneizumi, K / Kondo, K / Watanabe, T / Oishi, M et al. | 1991
- 310
-
143. Effects of 5-fluoro-2′-deoxyyridne-5′-monophosphate on morphological features and biological markers of a neoplastic human salivary intercalated duct cell line grown in culture and as xenograft in nude mouseKasai, Y / Yoshida, H / Sato, M et al. | 1991
- 311
-
145. Phenylacetate — A novel nontoxic inducer of tumor cell maturationSamid, D et al. | 1991
- 311
-
144. Induction of monocytic leukemia cell differentiation by nitric oxide, a stromal cell-derived, nonprotein growth-inhibiting moleculeWeinberg, JB / Magrinat, GC / Mason, SN / Shami, PJ et al. | 1991
- 312
-
146. Suppression of growth and induction of differentiation of oncogene-transformed granulosa cells upon synergistic action of cAMP and dêxamethasonePlehn-Dujowich, D / Keren-Tal, I / Suh, BS / Dantes, A / Amsterdam, A et al. | 1991
- 313
-
147. Roles for the heliodynamic hormones, 1α, 25-dihydroxyvitamin D3 and retinoids, in control of normal and malignous hematopoiesisBlazsek, I / Quittet, P / Liu, XH / Comisso, M / Farabos, C / Goldschmidt, E / Misset, JL / Blomhoff, R / Berg, T et al. | 1991
- 313
-
148, Combinations of 24,24-difluoro-1α,25-dihydroxyvitamin D3 and either retinoic acid, sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce monocytoid differentiation of the human myeloid leukemia cell line HL-60He, RY / Breitman, TR et al. | 1991
- 314
-
150. The effect of hexamethylene bisacetamide on the activity of DNA-interactive agents in human colon cancer cell linesConley, B / Wu, S / Pan, S / Egorin, M et al. | 1991
- 314
-
149. 8-CI-cAMP acts synergistically with tumor necrosis factor (TNFα), TGFβ, or retinoic acid (RA) in growth inhibition and differentiation of human leukemia and lymphoma cellsBudillon, A / Clair, T / Cho-Chung, YS et al. | 1991
- 315
-
151. Multistep model of terminal differentiation in human melanoma cells treated with the combination of recombinant human fibroblast Interferon (IFN-β) and mezerein (MEZ)Jiang, H / Su, Zz / Boyd, J / Fisher, PB et al. | 1991
- 315
-
152. Therapy with cytokines and biological response modifiers (BRMs) prior to syngeneic bone marrow transplantation in mice. Effect of recombinant human interleukin-1β (rhIL-1β), interleukin-2 (rhIL-2), interleukin-6 (rhIL-6), recombinant murine tumor necrosis factor α (rmTNFα), and Chinese herbal medicine, ninjin-youei-to (NYT) on immunohe-matologic reconstitutionFujii, Y / Imamura, M / Hashino, S / Kobayashi, H / Kobayashi, M / Kasai, M / Sakurada, K / Miyazaki, T et al. | 1991
- 316
-
153. Improved antinimor efficacy of a radiolabeled monoclonal antibody when combined with interferon-gammaGreiner, JW / Nieroda, C / Dansky-Ullmann, C / Schlom, J et al. | 1991
- 316
-
154. Effect of granulocyte-macrophage colony-stimulating factor on monocytic differentiation of acute promyelocytic leukemia cells in primary cultureNakamaki, T / Tsuruoka, N / Honma, Y / Kozumi, M et al. | 1991
- 317
-
155. The effects of combination treatment of interferon-α and 2-chlorodeoxyadenosine on hairy-cell leukemia-like cell lineRiter, Z / Tornson, S / Taylor, MW et al. | 1991
- 317
-
156. Enhancement of tumor cell killing in vitro by combinations of aclacinomycin A and radiationTofilon, PJ / Mendoza, EA / Vrdoljak, E / Bill, CA et al. | 1991
- 318
-
157. Tiazofurin (TR) treatment induced differentiation in patients with chronic granulocytic leukemia in blast crisis (CGL-BC) and was synergistic in HL-60 cells with ribavirin (RB), retinoic acid (RA) and gemcitabine (DFDC)Weber, G et al. | 1991
- 319
-
159. Clonogenic assays support a trial of trans-retinoic acid (tRA) therapy in accerated phase/early blastic crisis chronic myelogenous leukemia (CML-AP/BC)Gallagher, R / Sagayadan, G / Dutcher, J / Wiernik, P et al. | 1991
- 319
-
158. Strategy for the treatment of acute promyelocytic leukemia combining differentiation agent and cytotoxic drugsDegos, L / Castaigne, S / Daniel, MT / Pénaux, P et al. | 1991
- 320
-
160. All-trans retinoic acid (ATRA) and granulocyte colony-stimulating factor (G-CSF) in the treatment of myelodysplastic syndromes (MDS): a pilot studyGanser, A / Ottmann, OG / Kolbe, K / Maurer, A / Eisner, S / Geissler, G / Schardt, C / Reutzel, R / Hiddemann, W / Hoelzer, D et al. | 1991
- 320
-
161. Differentiation therapy with interferon-alpha plus low-dose cytarabine in acute monoblastic leukemia patientsHassan, HT / Maurer, HR et al. | 1991
- 321
-
163. Remission induction therapy of refractory acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA)Ohno, R / Yoshida, H / Naoe, T / Ohshima, T / Dohi, H / Endo, N / Fujimoto, T / Kobayashi, T / Hiraoka, A / Kodera, Y et al. | 1991
- 321
-
162. Phase II clinical trial with hexamethylene bisacetamide (HMBA) in myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML)Michaeli, J / Andreeff, M / Stone, R / Young, CL / Kufe, D / Rifkind, RA / Marks, Pa et al. | 1991
- 322
-
164. Effect of recombinant human stem cell factor on the proliferation and differentiation in vitro of hemopoietic progenitors in myeiodisplastic syndromesPiacibello, W / Sanavio, F / Fubini, L / Morelli, S / Séverine, A / Stacchini, A / Aglietta, M et al. | 1991
- 322
-
165. Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia (AML) patients by site-selective 8-chloro-cyclic adenosine 3′, 5′ monophasphate (8-CI-cAMP): a new approach for differentiation therapy of AML in humansPinto, A / Aldinucci, D / Gattei, V / Zagonel, V / Tortora, G / Budillon, A / Cho-Chung, YS et al. | 1991
- 323
-
166. 5-Aza-2′-deoxycytidine (decitabine) is an effective agent for differentiation therapy of advanced myelodysplastic syndromes (MDS)Zagonel, V / Pinto, A / Lo Re, G / Gattei, V / Aldinucci, D / Monfardini, S et al. | 1991
- 324
-
168. Induction of growth and differentiation in B-type chronic lymphocytic leukemia (B-CLL) cells by cytokines and thioredoxinRosen, A / Wendel-Hansen, V / Carlsson, M / Nilsson, K et al. | 1991
- 324
-
167. The proliferative rates of acute myelogenous leukemia cells can be accelerated or slowed in vivo in patientsPreisler, HD / Raza, A / Larson, R et al. | 1991
- 325
-
170. Differences in behaviour between AML and normal cells in long-term bone marrow culture used for a therapeutic approachTesta, NG / Coutinho, L / Chang, J / Morgenstern, G / Scarffe, H / Dexter, TM et al. | 1991
- 325
-
169. Phase I and pharmacokinetic evaluation of all-trans retinoic acid in pediatric patients and pharmacokinetic evaluation in the nonhuman primateSmith, MA / Adamson, PC / Baus, FM / Aronson, L / Murphy, RF / Godwin, KA / Feusner, J / Hammond, GD / Poplack, DG et al. | 1991
- 326
-
171. Clinical and pharmacologic aspects of all-trans retinoic acid treatment in acute promyelocytic leukemiaWarrell, RP Jr / Frankel, S / Miller, WH Jr / Muindi, J / Young, C / Dmitrovsky, E et al. | 1991
- 326
-
172. Randomized trial of alfacalcidol in the myelodysplastic syndromesYoshida, Y / Oguma, S / Uchino, H / Maekawa, T / Nomura, T et al. | 1991
- 327
-
173. Topical and systemic treatment of Kaposi's sarcoma with all-trans-retinoic acidBonhomme, L / Fredj, G / Averous, S / Szekely, AM / Blazsek, I / Ecstein, E / Trumbic, B / Meyer, P / Farabos, C / Jasmin, C et al. | 1991
- 328
-
174. Phase I trial of trans-retinoic acid (tra) in solid tumor patientsConley, B / Wu, S / Egorin, M / Hodges, S / Van Echo, D et al. | 1991
- 328
-
175. Oral cancer prevention studiesGarewal, H et al. | 1991
- 328
-
176. Upper GI tract premalignant lesions: Barrett's esophagus and gastric intestinal metaplasiaGarewal, H / Sampliner, R / Fennerty, B et al. | 1991
- 329
-
178. Phase-II trial of 13-cis retinoic acid (13cRA) plus interferon-α (IFN) in locally-advanced squamous cell carcinoma (SCC) of the cervixLippman, SM / Kavanagh, JJ / Paredes, M / Hong, WK / Lotan, R / Hua, H / Hittelman, W / Holdener, E / Krakoff, IH et al. | 1991
- 329
-
177. In situ analysis of human cervix cancer to 13-cis retinoic acid and alpha interferonHittelman, WN / Ahn, W / Silva, EG / Lippman, S / Kavanagh, JJ / Paredes-Espinoza, M / Hong, WK / Krakoff, IH et al. | 1991
- 330
-
180. Expression of the retinoic acid receptors and effect of retinoic acid on human primary neonatal melanocytes and metastatic melanoma cells strainsMeyskens, FL Jr / Yamanishi, DT / Buckmeier, JA / Graham, MJ / Voboril, JE et al. | 1991
- 330
-
179. Modulation of differentiation and growth of squamous carcinoma cells in vitro by retinoidsLotan, R / Clifford, J / Hong, W / Zou, C et al. | 1991
- 331
-
181. Analysis of genetic changes in non malignant bronchial epithelium, preneoplastic lesions and lung cancerSozzi, G / Miozzo, M / Cariani, CT / Tagliabue, E / Pastorino, U / Pilotti, S / Porta, G Delia / Pierotti, MA et al. | 1991
- 331
-
182. European chemoprevention trials in patients with lung cancer or head and neck cancer, using high dose retinol palmitate (RP) and N-acetyl-cysteine (NAC)Pastorino, U / Van Zandwijk, N / DeVries, N / Dalesio, O / Infante, M / Maioli, M / Valente, M / Ravasi, G et al. | 1991
- 332
-
184. All trans-retinoic acid inhibits the growth of human lung cancer cells and alter cytokine productionRoss, H / Voboril, J / Buckmeier, J et al. | 1991
- 332
-
183. Possible roles for interferon-α in remission of AIDS-related Kaposi's sarcomaReiter, Z / Taylor, MW et al. | 1991
- 333
-
185. Induction of cells with phenotypic features of smooth muscle cells by treatment with DNA topoisomeras I inhibitor, etoposide, in a neoplastic human salivary intercalated duct cell lineTakase, M / Yoshida, H / Sato, M et al. | 1991
- 333
-
186. Transcriptional up-regulation of interleukin-2 receptors by retinoic acid is mediated by interactions with negative regulatory elements in the interleukin-2-receptor promoterSidell, N / Bhatti, L et al. | 1991
- 335
-
Author index| 1991
- I
-
5th International Congress on Differentiation Therapy| 1991